Real-world Safety of Vedolizumab and Anti-TNF Therapies in Biologic-Naïve Ulcerative Colitis and Crohn's Disease Patients: Results from the EVOLVE study
Andres Yarur 1
Gerassimos J. Mantzaris 2
Uri Kopylov 3
Marielle Bassel 4
Neil Brett 4
Trevor Lissoos 5
claudia lopez 5
Athanasios Natsios 6
Christina Kifnidi 7
Sumit Saha
Dirk Demuth
Haridarshan Patel
Brian Bressler
1 Medical College of Wisconsin,Milwaukee,United States
2 Evangelismos Hospital,Athens,Greece
3 Chaim Sheba Medical Center,Ramat Gan,Israel
4 Evidera,Montreal,Canada
5 Takeda Pharmaceuticals USA Inc,Deerfield,United States
6 Takeda Hellas S.A.,Athens,Greece
7 T
Session
IBD: New drugs, new risks
Conference
UEG Week 2019
Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing